1.24
Bionano Genomics Inc stock is traded at $1.24, with a volume of 217.96K.
It is up +0.81% in the last 24 hours and down -0.80% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
See More
Previous Close:
$1.23
Open:
$1.23
24h Volume:
217.96K
Relative Volume:
0.80
Market Cap:
$14.23M
Revenue:
$28.51M
Net Income/Loss:
$-26.40M
P/E Ratio:
-0.2265
EPS:
-5.4756
Net Cash Flow:
$-16.35M
1W Performance:
+7.83%
1M Performance:
-0.80%
6M Performance:
-23.46%
1Y Performance:
-67.11%
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BNGO
Bionano Genomics Inc
|
1.24 | 14.11M | 28.51M | -26.40M | -16.35M | -5.4756 |
|
ISRG
Intuitive Surgical Inc
|
438.10 | 155.76B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
147.63 | 40.30B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
67.78 | 33.13B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
37.01 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
208.05 | 30.31B | 5.54B | 1.52B | 1.74B | 10.37 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
Bionano Genomics Q4 2026 earnings preview - MSN
BNGO News | BIONANO GENOMICS INC (NASDAQ:BNGO) - ChartMill
Earnings call transcript: Bionano Genomics sees Q1 revenue growth, stock edges up - Investing.com Canada
Q1 2026 Bionano Genomics Inc Earnings Call Transcript - GuruFocus
Bionano outlines $30M-$33M 2026 revenue guidance as it expects flow cell supply to improve - MSN
Bionano Genomics, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-05-16 - Seeking Alpha
Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2026 Earnings Call Transcript - Insider Monkey
BNGO Should I Buy - Intellectia AI
Bionano Genomics shareholders elect directors and approve proposals at annual meeting - Investing.com Nigeria
Bionano Genomics (NASDAQ: BNGO) director awarded 9,149 options - Stock Titan
Bionano Genomics (BNGO) director granted 9,149 stock options at $1.19 - Stock Titan
Bionano Genomics (BNGO) director awarded 9,149 stock options vesting over 12 months - Stock Titan
Bionano Genomics (BNGO) director receives grant of 9,149 stock options at $1.19 - Stock Titan
Bionano Genomics (BNGO) director receives stock option grant for 9,149 shares - Stock Titan
BioNano Genomics Stockholders Approve 2026 Annual Meeting Proposals - TipRanks
Bionano Genomics 1Q Rev $6.7M >BNGO - Moomoo
Bionano Genomics (NASDAQ: BNGO) reports 2026 shareholder voting results - Stock Titan
Bionano Genomics, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Bionano Reports First Quarter 2026 Results and Provides a Business Update - The Manila Times
Bionano Genomics Inc (BNGO) Q1 2026 Earnings Call Highlights: Re - GuruFocus
Is Bionano Genomics (BNGO) Undervalued After Q1 2026? EPS not di - GuruFocus
Bionano Genomics, Inc. (BNGO) reports Q1 loss, tops revenue estimates - MSN
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
BNGO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Bionano Genomics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
BNGO: Q1 2026 saw 4% revenue growth, record flow cell sales, and improved gross margin, with strong outlook - TradingView
Earnings call transcript: Bionano Genomics Q1 2026 shows revenue growth By Investing.com - Investing.com South Africa
Earnings call transcript: Bionano Genomics Q1 2026 shows revenue growth - Investing.com
BNGO: Q1 2026 saw revenue and margin growth, record flow cell sales, and strengthened reimbursement - TradingView
Transcript: Bionano Genomics Q1 2026 Earnings Conference Call - Yahoo Finance
BIONANO GENOMICS ($BNGO) Releases Q1 2026 Earnings - Moomoo
Bionano Genomics Q1 revenue up 4%, margin improves; to retire convertible debt - TradingView
Bionano Genomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Bionano Genomics (NASDAQ: BNGO) posts Q1 2026 loss and warns on going concern - Stock Titan
Bionano Genomics, Inc. Provides Revenue Guidance for the Second Quarter of the Year 2026 - marketscreener.com
Bionano Genomics (BNGO) posts Q1 2026 loss on $6.7M revenue and lifts OGM reimbursement - Stock Titan
Bionano Genomics Q1 2026 Earnings Call Transcript - MarketBeat
バイオナノ、2026年第1四半期の決算を発表し事業状況を報告 - Moomoo
TradingKey - TradingKey
Bionano Genomics Inc (BNGO) Q1 2026 Earnings Report Preview: Wha - GuruFocus
BNGO Q1'26 Earnings: EPS estimate is (0.88) USD - TradingView
Bionano Genomics Inc expected to post a loss of 95 cents a shareEarnings Preview - TradingView
Bionano raises 2025 OGM installation target to 25 as consumables and software revenue climbs 16% - MSN
Bionano Genomics may offer and sell up to $400 mln of securitiesSEC filing - marketscreener.com
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):